nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications
|
Yu, P. H. |
|
1997 |
40 |
11 |
p. 1243-1250 |
artikel |
2 |
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications
|
Yu, P. H. |
|
1997 |
40 |
11 |
p. 1243-1250 |
artikel |
3 |
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications
|
Yu, P. H. |
|
|
40 |
11 |
p. 1243-1250 |
artikel |
4 |
Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features
|
|
|
1997 |
40 |
11 |
p. 1364-1365 |
artikel |
5 |
Anti-ganglioside GM1 antibody and distal symmetric “diabetic polyneuropathy” with dominant motor features
|
Milicevic, Z. |
|
1997 |
40 |
11 |
p. 1364-1365 |
artikel |
6 |
Cardiac disease in diabetic end-stage renal disease
|
Foley, R. N. |
|
1997 |
40 |
11 |
p. 1307-1312 |
artikel |
7 |
Cardiac disease in diabetic end-stage renal disease
|
Foley, R. N. |
|
1997 |
40 |
11 |
p. 1307-1312 |
artikel |
8 |
Cardiac disease in diabetic end-stage renal disease
|
Foley, R. N. |
|
|
40 |
11 |
p. 1307-1312 |
artikel |
9 |
Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment
|
Vér, Á |
|
1997 |
40 |
11 |
p. 1255-1262 |
artikel |
10 |
Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment
|
Vér, 'A. |
|
1997 |
40 |
11 |
p. 1255-1262 |
artikel |
11 |
Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: effect of insulin treatment
|
Vér, Á |
|
|
40 |
11 |
p. 1255-1262 |
artikel |
12 |
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia
|
Sainsbury, A. |
|
1997 |
40 |
11 |
p. 1269-1277 |
artikel |
13 |
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia
|
Sainsbury, A. |
|
1997 |
40 |
11 |
p. 1269-1277 |
artikel |
14 |
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia
|
Sainsbury, A. |
|
|
40 |
11 |
p. 1269-1277 |
artikel |
15 |
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
|
Hatfield, E. C. I. |
|
1997 |
40 |
11 |
p. 1327-1333 |
artikel |
16 |
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
|
Hatfield, E. C. I. |
|
1997 |
40 |
11 |
p. 1327-1333 |
artikel |
17 |
Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
|
Hatfield, E. C. I. |
|
|
40 |
11 |
p. 1327-1333 |
artikel |
18 |
Effects of 4 weeks’ administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations
|
Thompson, R. G. |
|
1997 |
40 |
11 |
p. 1278-1285 |
artikel |
19 |
Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations
|
Thompson, R. G. |
|
1997 |
40 |
11 |
p. 1278-1285 |
artikel |
20 |
Effects of 4 weeks’ administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations
|
Thompson, R. G. |
|
|
40 |
11 |
p. 1278-1285 |
artikel |
21 |
Evidence that insulin can directly inhibit hepatic glucose production
|
Maheux, P. |
|
1997 |
40 |
11 |
p. 1300-1306 |
artikel |
22 |
Evidence that insulin can directly inhibit hepatic glucose production
|
Maheux, P. |
|
1997 |
40 |
11 |
p. 1300-1306 |
artikel |
23 |
Evidence that insulin can directly inhibit hepatic glucose production
|
Maheux, P. |
|
|
40 |
11 |
p. 1300-1306 |
artikel |
24 |
Factor V Leiden mutation and Japanese NIDDM
|
Odawara, M. |
|
1997 |
40 |
11 |
p. 1363-1364 |
artikel |
25 |
Factor V Leiden mutation and Japanese NIDDM
|
Odawara, M. |
|
1997 |
40 |
11 |
p. 1363-1364 |
artikel |
26 |
Factor V Leiden mutation and Japanese NIDDM
|
Odawara, M. |
|
|
40 |
11 |
p. 1363-1364 |
artikel |
27 |
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations
|
Hattersley, A. T. |
|
1997 |
40 |
11 |
p. 1367-1368 |
artikel |
28 |
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations
|
Hattersley, A. T. |
|
|
40 |
11 |
p. 1367-1368 |
artikel |
29 |
Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin
|
Fraser, R. B. |
|
1997 |
40 |
11 |
p. 1263-1268 |
artikel |
30 |
Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin
|
Fraser, R. B. |
|
1997 |
40 |
11 |
p. 1263-1268 |
artikel |
31 |
Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin
|
Fraser, R. B. |
|
|
40 |
11 |
p. 1263-1268 |
artikel |
32 |
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
|
Kellerer, M. |
|
1997 |
40 |
11 |
p. 1358-1362 |
artikel |
33 |
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
|
Kellerer, M. |
|
1997 |
40 |
11 |
p. 1358-1362 |
artikel |
34 |
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
|
Kellerer, M. |
|
|
40 |
11 |
p. 1358-1362 |
artikel |
35 |
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland
|
Rissanen, J. |
|
1997 |
40 |
11 |
p. 1313-1319 |
artikel |
36 |
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland
|
Rissanen, J. |
|
1997 |
40 |
11 |
p. 1313-1319 |
artikel |
37 |
New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland
|
Rissanen, J. |
|
|
40 |
11 |
p. 1313-1319 |
artikel |
38 |
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
|
Pickup, J. C. |
|
1997 |
40 |
11 |
p. 1286-1292 |
artikel |
39 |
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
|
Pickup, J. C. |
|
1997 |
40 |
11 |
p. 1286-1292 |
artikel |
40 |
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X
|
Pickup, J. C. |
|
|
40 |
11 |
p. 1286-1292 |
artikel |
41 |
Possible role of free radicals generated by pseudohypoxia in the regulation of hepatic glucose output. An in vitro model using rat liver microsomal glucose 6-phosphatase
|
Wittmann, I. |
|
1997 |
40 |
11 |
p. 1251-1254 |
artikel |
42 |
Possible role of free radicals generated by pseudohypoxia in the regulation of hepatic glucose output. An in vitro model using rat liver microsomal glucose 6-phosphatase
|
Wittmann, I. |
|
1997 |
40 |
11 |
p. 1251-1254 |
artikel |
43 |
Possible role of free radicals generated by pseudohypoxia in the regulation of hepatic glucose output. An in vitro model using rat liver microsomal glucose 6-phosphatase
|
Wittmann, I. |
|
|
40 |
11 |
p. 1251-1254 |
artikel |
44 |
Preliminary data on a genome search in NIDDM siblings: the NIDDM 1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population
|
Ciccarese, M. |
|
1997 |
40 |
11 |
p. 1366-1367 |
artikel |
45 |
Preliminary data on a genome search in NIDDM siblings: the NIDDM 1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population
|
Ciccarese, M. |
|
|
40 |
11 |
p. 1366-1367 |
artikel |
46 |
Preliminary data on a wide genome search in NIDDM siblings: the NIDDM1 locus on chromosome 2 is not linked to NIDDM in the Sardinian population
|
Ciccarese, M. |
|
1997 |
40 |
11 |
p. 1366-1367 |
artikel |
47 |
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia
|
Moberg, E. |
|
1997 |
40 |
11 |
p. 1320-1326 |
artikel |
48 |
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia
|
Moberg, E. |
|
1997 |
40 |
11 |
p. 1320-1326 |
artikel |
49 |
Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia
|
Moberg, E. |
|
|
40 |
11 |
p. 1320-1326 |
artikel |
50 |
Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study
|
Brunner, E. J. |
|
1997 |
40 |
11 |
p. 1341-1349 |
artikel |
51 |
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study
|
Brunner, E. J. |
|
1997 |
40 |
11 |
p. 1341-1349 |
artikel |
52 |
Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study
|
Brunner, E. J. |
|
|
40 |
11 |
p. 1341-1349 |
artikel |
53 |
Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study
|
Sonnaville, J. J. J. de |
|
1997 |
40 |
11 |
p. 1334-1340 |
artikel |
54 |
Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study
|
de Sonnaville, J. J. J. |
|
1997 |
40 |
11 |
p. 1334-1340 |
artikel |
55 |
Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study
|
de Sonnaville, J. J. J. |
|
|
40 |
11 |
p. 1334-1340 |
artikel |
56 |
Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM
|
Doria, A. |
|
1997 |
40 |
11 |
p. 1293-1299 |
artikel |
57 |
Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM
|
Doria, A. |
|
1997 |
40 |
11 |
p. 1293-1299 |
artikel |
58 |
Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM
|
Doria, A. |
|
|
40 |
11 |
p. 1293-1299 |
artikel |
59 |
The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990
|
Schiel, R. |
|
1997 |
40 |
11 |
p. 1350-1357 |
artikel |
60 |
The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990
|
Schiel, R. |
|
1997 |
40 |
11 |
p. 1350-1357 |
artikel |
61 |
The JEVIN trial: A population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990
|
Schiel, R. |
|
|
40 |
11 |
p. 1350-1357 |
artikel |